{
    "id": "f0d9d7a8-1d06-4119-b2bc-42b3ec08d45b",
    "indications": {
        "text": "carbidopa , levodopa entacapone tablets , indicated treatment parkinson \u2019 disease . carbidopa , levodopa entacapone tablets used : substitute ( equivalent strengths three components ) carbidopa/levodopa entacapone previously administered individual products . replace carbidopa/levodopa therapy ( without entacapone ) patients experience signs symptoms end-of-dose \u201c wearing-off \u201d taking total daily dose levodopa 600 mg less experiencing dyskinesias .",
        "doid_entities": [
            {
                "text": "disease (DOID:4)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_4"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "carbidopa , levodopa entacapone tablets used substitute patients already stabilized equivalent doses carbidopa/levodopa entacapone . however , patients stabilized given dose carbidopa/levodopa may treated carbidopa , levodopa entacapone tablets decision made add entacapone ( ) . therapy individualized adjusted according desired therapeutic response .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "carbidopa , levodopa entacapone ) supplied film-coated tablets oral following six strengths : carbidopa , levodopa entacapone film coated tablets 12.5 mg/50 mg/200 mg containing 12.5 mg carbidopa , 50 mg levodopa , 200 mg entacapone . brown coloured , round shaped , biconvex , film coated tablets debossed `` 71 `` one side plain surface side . hdpe bottle 100 tablets ndc 33342-491-11 100 tablets ( 10 x 10 unit-dose ) ndc 33342-491-12 carbidopa , levodopa entacapone film coated tablets 18.75 mg/75 mg/200 mg containing 18.75 mg carbidopa , 75 mg levodopa , 200 mg entacapone . brown coloured , oval shaped , biconvex , film coated tablets debossed `` 72 `` one side plain surface side . hdpe bottle 100 tablets ndc 33342-492-11 100 tablets ( 10 x 10 unit-dose ) ndc 33342-492-12 carbidopa , levodopa entacapone film coated tablets 25 mg/100 mg/200 mg containing 25 mg carbidopa , 100 mg levodopa , 200 mg entacapone . brown coloured , oval shaped , biconvex , film coated tablets debossed `` 73 `` one side plain surface side . hdpe bottle 100 tablets ndc 33342-493-11 100 tablets ( 10 x 10 unit-dose ) ndc 33342-493-12 carbidopa , levodopa entacapone film coated tablets 31.25 mg/125 mg/200 mg containing 31.25 mg carbidopa , 125 mg levodopa , 200 mg entacapone . brown coloured , oval shaped , biconvex , film coated tablets debossed `` 74 `` one side plain surface side . hdpe bottle 100 tablets ndc 33342-494-11 100 tablets ( 10 x 10 unit-dose ) ndc 33342-494-12 carbidopa , levodopa entacapone film coated tablets 37.5 mg/150 mg/200 mg containing 37.5 mg carbidopa , 150 mg levodopa , 200 mg entacapone . brown coloured , oval shaped , biconvex , film coated tablets debossed `` 75 `` one side plain surface side . hdpe bottle 100 tablets ndc 33342-495-11 100 tablets ( 10 x 10 unit-dose ) ndc 33342-495-12 carbidopa , levodopa entacapone film coated tablets 50 mg/200 mg/200 mg containing 50 mg carbidopa , 200 mg levodopa , 200 mg entacapone . brown coloured , oval shaped , biconvex , film coated tablets debossed `` 70 `` one side plain surface side . hdpe bottle 100 tablets ndc 33342-496-11 100 tablets ( 10 x 10 unit-dose ) ndc 33342-496-12 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense tight container ( usp ) .",
    "adverseReactions": "carbidopa , levodopa entacapone tablets contraindicated patients : taking nonselective monoamine oxidase ( mao ) inhibitors ( e.g . , phenelzine tranylcypromine ) . nonselective mao inhibitors must discontinued least two weeks prior initiating therapy carbidopa , levodopa entacapone tablets . narrow-angle glaucoma .",
    "ingredients": [
        {
            "name": "CARBIDOPA",
            "code": "MNX7R8C5VO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3395"
        },
        {
            "name": "LEVODOPA",
            "code": "46627O600J",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01235"
        },
        {
            "name": "ENTACAPONE",
            "code": "4975G9NM6T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_4798"
        },
        {
            "name": "MALTODEXTRIN",
            "code": "7CVR7L4A2D",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25140"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CROSPOVIDONE",
            "code": "68401960MK"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "POLYSORBATE 80",
            "code": "6OZP39ZG8H",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53426"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50819"
        }
    ],
    "organization": "Macleods Pharmaceuticals Limited",
    "name": "Carbidopa, Levodopa and Entacapone",
    "effectiveTime": "20250424",
    "indications_original": "Carbidopa, levodopa and entacapone tablets, is indicated for the treatment of Parkinson\u2019s disease.  Carbidopa, levodopa and entacapone tablets can be used:\u00a0 \n                  \n                     To substitute (with equivalent strengths of each of the three components) carbidopa/levodopa and entacapone previously administered as individual products.\n                     To replace carbidopa/levodopa therapy (without entacapone) when patients experience the signs and symptoms of end-of-dose \u201cwearing-off\u201d and when they have been taking a total daily dose of levodopa of 600 mg or less and have not been experiencing dyskinesias.",
    "contraindications_original": "Carbidopa, levodopa and entacapone tablets should be used as a substitute for patients already stabilized on equivalent doses of carbidopa/levodopa and entacapone. However, some patients who have been stabilized on a given dose of carbidopa/levodopa may be treated with Carbidopa, levodopa and entacapone tablets if a decision has been made to add entacapone (see below). Therapy should be individualized and adjusted according to the desired therapeutic response.",
    "warningsAndPrecautions_original": "Carbidopa, levodopa and entacapone) is supplied as film-coated tablets for oral administration in the following six strengths:\n                  \n                     Carbidopa, levodopa and entacapone film coated tablets 12.5 mg/50 mg/200 mg containing 12.5 mg of carbidopa, 50 mg of levodopa, and 200 mg of entacapone.\u00a0 Brown coloured, round shaped, biconvex, film coated tablets debossed with \"M 71\" on one side and plain surface on the other side.\u00a0 HDPE bottle of 100 tablets NDC 33342-491-11 100 Tablets (10 x 10 Unit-dose) NDC 33342-491-12\n                     \n                         Carbidopa, levodopa and entacapone film coated tablets 18.75 mg/75 mg/200 mg containing 18.75 mg of carbidopa, 75 mg of levodopa, and 200 mg of entacapone.\u00a0 Brown coloured, oval shaped, biconvex,\u00a0 film coated tablets debossed with \"M 72\" on one side and plain surface on the other side.\u00a0 HDPE bottle of 100 tablets NDC 33342-492-11 100 Tablets (10 x 10 Unit-dose) NDC 33342-492-12\n                     \n                     Carbidopa, levodopa and entacapone film coated tablets 25 mg/100 mg/200 mg containing 25 mg of carbidopa, 100 mg of levodopa, and 200 mg of entacapone. Brown coloured, oval shaped, biconvex, film coated tablets debossed with \"M 73\" on one side and plain surface on the other side.\u00a0 HDPE bottle of 100 tablets NDC 33342-493-11 100 Tablets (10 x 10 Unit-dose) NDC 33342-493-12\n                     \n                     Carbidopa, levodopa and entacapone film coated tablets 31.25 mg/125 mg/200 mg containing 31.25 mg of carbidopa, 125 mg of levodopa, and 200 mg of entacapone.\u00a0 Brown coloured, oval shaped, biconvex, \u00a0film coated tablets debossed with \"M 74\" on one side and plain surface on the other side.\u00a0 HDPE bottle of 100 tablets NDC 33342-494-11 100 Tablets (10 x 10 Unit-dose) NDC 33342-494-12\n                     \n                     Carbidopa, levodopa and entacapone film coated tablets 37.5 mg/150 mg/200 mg containing 37.5 mg of carbidopa, 150 mg of levodopa, and 200 mg of entacapone. Brown coloured, oval shaped, biconvex, \u00a0film coated tablets debossed with \"M 75\" on one side and plain surface on the other side.\u00a0 HDPE bottle of 100 tablets NDC 33342-495-11 100 Tablets (10 x 10 Unit-dose) NDC 33342-495-12\n                     \n                     Carbidopa, levodopa and entacapone film coated tablets 50 mg/200 mg/200 mg containing 50 mg of carbidopa, 200 mg of levodopa, and 200 mg of entacapone. Brown coloured, oval shaped, biconvex, \u00a0film coated tablets debossed with \"M 70\" on one side and plain surface on the other side.\u00a0 HDPE bottle of 100 tablets NDC 33342-496-11 100 Tablets (10 x 10 Unit-dose) NDC 33342-496-12 \u00a0 Store at\u00a020\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted between 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F)\u00a0[See USP Controlled Room Temperature].  Dispense in tight container (USP).",
    "adverseReactions_original": "Carbidopa, levodopa and entacapone tablets is contraindicated in patients:\u00a0\u00a0\n                  \n                  \n                     Taking nonselective monoamine oxidase (MAO) inhibitors (e.g., phenelzine and tranylcypromine). These nonselective MAO inhibitors must be discontinued at least two weeks prior to initiating therapy with Carbidopa, levodopa and entacapone tablets.\n                     With narrow-angle glaucoma.",
    "drug": [
        {
            "name": "Carbidopa, Levodopa and Entacapone",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_3395"
        }
    ]
}